Gossamer Bio, Inc. held a special meeting of stockholders on October 27, 2026. Stockholders approved, in accordance with Nasdaq Listing Rules 5635(c) and 5635(d), the potential issuance of shares of the Company's common stock, par value $0.0001 per share, pursuant to the Securiti